Table I.
Number of patients with an antimicrobial-resistant organism at and during admission
| Organism | Initial sample positive N (%) 97 patients |
Negative on initial sample and became colonized during admission N (%) 97 patients |
||||
|---|---|---|---|---|---|---|
| 3GC-R | ESBL | IPM-R | 3GC-R | ESBL | IPM-R | |
| Escherichia coli | 7 (7) | 7 (7) | 0 | 5 (5) | 5 (5) | 3 (3) |
| Enterobacter spp. | 15 (15.5) | - | 0 | 19 (19.2) | - | 3 (3) |
| Klebsiella pneumoniae | 26 (26.8) | 25 (25.7) | 17 (17.5) | 22 (22.7) | 21 (21.6) | 25 (25.2) |
| Acinetobacter spp. | 25 (25.3) | - | 22 (22.2) | 29 (29.9) | - | 30 (30.1) |
| Pseudomonas aeruginosa | 11 (11.1) | - | 12 (12.4) | 30 (30.3) | - | 32 (32.3) |
| Any of the above organisms | 48 (49.5) | 26 (26.8) | 37 (38.1) | 21 (21.2) | 24 (24.3) | 25 (25.8) |
3GC-R, third-generation cephalosporin-resistant; ESBL, extended-spectrum beta-lactamase; IPM-R, imipenem-resistant.